Dose flexibility of oral Janus kinase inhibitors for long-term control of atopic dermatitis

Br J Dermatol. 2023 Feb 10;188(2):165. doi: 10.1093/bjd/ljac082.

Author

Toshiya Ebata^{1

2}

Affiliations

¹ Chitofuna Dermatology Clinic, Tokyo, Japan.
² Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan.

PMID: 36653323
DOI: 10.1093/bjd/ljac082

No abstract available

MeSH terms

Dermatitis, Atopic* / drug therapy
Double-Blind Method
Humans
Janus Kinase 1
Janus Kinase Inhibitors*
Treatment Outcome

Substances

Janus Kinase Inhibitors
Janus Kinase 1